NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Fibroblast Growth Factor 23 in Long-Duration SpaceflightMany nutritional factors influence bone, from the basics of calcium and vitamin D, to factors which influence bone through acid/base balance, including protein, sodium, and more. Fibroblast growth factor 23 (FGF23) is a recently identified factor, secreted from osteocytes, which is involved in classic (albeit complex) feedback loops controlling phosphorus homeostasis through both vitamin D and parathyroid hormone (PTH) (1, 2). As osteocytes are gravity sensing cells, it is important to determine if there are changes in FGF23 during spaceflight. In extreme cases, such as chronic kidney disease, FGF23 levels are highly elevated. FGF23 imbalances, secondary to dietary influences, may contribute to skeletal demineralization and kidney stone risk during spaceflight.
Document ID
20150001900
Acquisition Source
Johnson Space Center
Document Type
Presentation
Authors
Bokhari, R.
(Texas A&M Univ. College Station, TX, United States)
Zwart, S. R.
(Universities Space Research Association Houston, TX, United States)
Fields, E.
(Enterprise Advisory Services, Inc. Houston, TX, United States)
Heer, M.
(Bonn Univ. Germany)
Sibonga, J.
(NASA Johnson Space Center Houston, TX, United States)
Smith, S. M.
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
February 20, 2015
Publication Date
January 13, 2015
Subject Category
Life Sciences (General)
Aerospace Medicine
Report/Patent Number
JSC-CN-32718
Meeting Information
Meeting: 2015 Human Research Program Investigator''s Workshop
Location: Galveston, TX
Country: United States
Start Date: January 13, 2015
End Date: January 15, 2015
Sponsors: National Space Biomedical Research Inst.
Funding Number(s)
CONTRACT_GRANT: NCC-9-58
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available